Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$SABS

SAB Biotherapeutics, Inc. Common Stock

XNASHealth CareBiological Products, (No Diagnostic Substances)

$3.78
+2.16%+$0.080
RVOL peak today
Normal
Halted today
None today
Float
20.8M
Next earnings
Unscheduled
$3.78+2.16%+$0.0800Prev $3.70LIVE Full chart Live alerts
No recent price bars, the chart lights up when SABS starts printing.

Why is SABS up today? It is at $3.78 (+2.16%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SABS spikes, and full due diligence on SABS — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $SABS alerts the moment volume spikes

Our scanner flagged $SABS 2 times in the last 30 days. Create a free account to track $SABS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$3.78
Change today
+2.16%
Previous close
$3.70
52-week range
$1.85 – $5.15
Valuation & dividend
Market cap
$344M
Ownership & volume
Shares outstanding
91.0M
SEC · as of 2026-08-03 · 20d
Institutional own.
77.17%
Total held
77.2%
Tradeable float
20.8M
23% of shares · after 77% institutions
Short interest
4.7M
▲ +6% vs prior · as of 2026-07-31
Short % of float
22.4%
Days to cover
8.9d
Avg daily volume
526K
Classification
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
XNAS
Relative volumevs this time of day
5m
0.0x
15m
0.1x
1h
0.2x
1D
--

Get free SABS + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $SABS up today?

Here is the latest on SABS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SABS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystSAB Biotherapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →
Why is $SABS moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile🔥 Heavily shorted · 22% of floatNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201

Dilution watch

Unavailable

We could not reach SEC EDGAR, so the dilution check did not run for $SABS. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.

$SABS Sentiment

Bullish
Bearish84Bullish
📰 News: 4 bull · 0 bearToday: +2.2%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$SABS Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

News· SEC EDGAR· 17d ago
SAB Biotherapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026
Alert· 18d ago +2.9% vs EMA
SABS 200EMA (5m) Trending · 74 bars · L3 · +2.92% above EMA · slope +0.91%
at $3.85
Alert· 19d ago 5.8× RVOL
SABS hit 5.843x RVOL at 2:07 PM ET
at $3.94
Alert· 19d ago 4.8× RVOL
SABS hit 4.777x RVOL at 11:21 AM ET
at $3.89
Alert· 31d ago +0.5% vs EMA
$SABS near 200 EMA: +0.51% from 200 EMA at 12:42 PM ET
at $3.61
Alert· 31d ago 16.4× RVOL
SABS hit 16.380x RVOL at 12:42 PM ET
at $3.61
News· SEC EDGAR· 47d ago
SAB Biotherapeutics, Inc.: Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
News· SEC EDGAR· 65d ago
SAB Biotherapeutics, Inc. filed an 8-K: Shareholder Vote
News· SEC EDGAR· 103d ago
SAB Biotherapeutics, Inc. filed a Quarterly report (10-Q)
News· Benzinga· 158d ago Bullish
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
News· GlobeNewswire Inc.· 158d ago Bullish
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
News· GlobeNewswire Inc.· 200d ago Bullish
SAB BIO to Participate in Upcoming Investor Conferences
News· GlobeNewswire Inc.· 228d ago Bullish
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

SABS stock FAQ

Why is $SABS up today?

Here is the latest on SABS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SABS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the SABS stock price today?

SABS last traded at $3.78, up 2.16% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live SABS alerts?

The SABS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SABS 2 times in the last 30 days.

What exchange is SABS on?

SABS (SAB Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $344M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.

Is SABS good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SABS for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.